Under the coordination of KU Leuven, the consortium of partners from diverse disciplines, including clinical experts, medical practitioners, data scientists, and health economists, will be working on pioneering personalised therapies for brain cancer patients.
GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany
From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.
